Dr. Alexandra Charrow , MD
Dermatology โข Boston, MA
221 Longwood Ave
Boston, MA 021155804
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 5, 2014; this date does not establish years in practice.
-
Published CMS data list 985 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 17003 โ Destruction of precancer skin growth, 2-14 growths: 251 service units.
- 99214 โ Established patient outpatient office visit: 249 service units.
- 17000 โ Destruction of precancer skin growth, 1 growth: 99 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 12 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 978 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Cosentyx Sensoready (2 Pens) (Secukinumab) โ 98 prescription fills, including refills.
- Doxycycline Monohydrate โ 67 prescription fills, including refills.
- Ketoconazole โ 63 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 31 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Dermatology in Boston, MA (2024, 150 clinicians with data). Median for this group: 974. Middle half: 419 to 1,817.
Fewer Medicare Part B services than 65% of clinicians listed under Dermatology in Massachusetts (2024, 412 clinicians with data). Median for this group: 1,804. Middle half: 853 to 3,570.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 402 in 2020 to 985 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
221 Longwood Ave
Boston, MA 021155804
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Boston, MA. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Brigham And Womens Physicians Organization Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Perelman School Of Med At The University Of Pennsylvania
2014
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
333 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $75,171 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $54,633 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
1,226 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,484,956 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $10,961.00 across 11 records.
By nature of payment
- Consulting Fee: $9,750.00 across 2 records.
- Travel and Lodging: $1,001.72 across 4 records.
- Food and Beverage: $209.28 across 5 records.
Reporting-company totals
- Incyte Corporation: $9,393.97 across 9 records.
- UCB, Inc.: $1,567.03 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
12 years (graduated 2014)
CMS Doctors and Clinicians data list 2014 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2014
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Charrow has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Charrow as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Boston and Massachusetts
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Dermatology in Boston, MA (2024, 150 clinicians with data). Median for this group: 974. Middle half: 419 to 1,817.
Fewer Medicare Part B services than 65% of clinicians listed under Dermatology in Massachusetts (2024, 412 clinicians with data). Median for this group: 1,804. Middle half: 853 to 3,570.
Medicare-allowed amount
Close to the middle for clinicians listed under Dermatology in Boston, MA (2024, 150 clinicians with data). Median for this group: $69,763. Middle half: $23,981 to $120,156.
A lower Medicare-allowed amount than 65% of clinicians listed under Dermatology in Massachusetts (2024, 412 clinicians with data). Median for this group: $123,974. Middle half: $61,150 to $257,057.
Paid by Medicare
Close to the middle for clinicians listed under Dermatology in Boston, MA (2024, 150 clinicians with data). Median for this group: $49,275. Middle half: $17,385 to $84,821.
A lower Medicare payment amount than 65% of clinicians listed under Dermatology in Massachusetts (2024, 412 clinicians with data). Median for this group: $86,263. Middle half: $42,834 to $181,359.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Dermatology in Boston, MA (2024, 180 clinicians with data). Median for this group: 224. Middle half: 89 to 573.
More Part D prescriptions than 80% of clinicians listed under Dermatology in Massachusetts (2024, 458 clinicians with data). Median for this group: 433. Middle half: 155 to 825.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Dermatology in Boston, MA (2024, 180 clinicians with data). Median for this group: $72,714. Middle half: $3,461 to $279,125.
A higher Part D drug cost than 95% of clinicians listed under Dermatology in Massachusetts (2024, 458 clinicians with data). Median for this group: $90,594. Middle half: $5,876 to $363,288.
266 active clinicians are listed under Dermatology with a practice address in Boston, MA (627 in Massachusetts).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Boston
18.4% of these 266 clinicians have the CMS telehealth indicator.
63.9% of these 266 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 145% from 402 in 2020 to 985 in 2024.
- 2020: 402
- 2021: 791
- 2022: 842
- 2023: 928
- 2024: 985
-
Medicare-allowed amount
Medicare-allowed amount increased 187% from $26,220 in 2020 to $75,171 in 2024.
- 2020: $26,220
- 2021: $68,187
- 2022: $71,472
- 2023: $72,985
- 2024: $75,171
-
Paid by Medicare
Paid by Medicare increased 207% from $17,786 in 2020 to $54,633 in 2024.
- 2020: $17,786
- 2021: $51,011
- 2022: $51,238
- 2023: $52,872
- 2024: $54,633
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 323% from 231 in 2020 to 978 in 2024.
- 2020: 231
- 2021: 334
- 2022: 669
- 2023: 803
- 2024: 978
-
30-day fills
30-day fills increased 374% from 259 in 2020 to 1,226 in 2024.
- 2020: 259
- 2021: 379
- 2022: 804
- 2023: 984
- 2024: 1,226
-
Part D drug cost
Part D drug cost increased 2822% from $85,053 in 2020 to $2,484,956 in 2024.
- 2020: $85,053
- 2021: $248,661
- 2022: $1,092,097
- 2023: $1,988,394
- 2024: $2,484,956
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 23% from $8,900.34 in 2022 to $10,961.00 in 2025.
- 2022: $8,900.34
- 2023: $3,610.00
- 2024: $420.00
- 2025: $10,961.00
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 11 records totaling $10,961.00.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Incyte Corporation |
Consulting Fee
Cash or cash equivalent
|
โ | General | $8,250.00 |
| UCB, Inc. |
Consulting Fee
Cash or cash equivalent
|
Bimzelx | General | $1,500.00 |
| Incyte Corporation |
Travel and Lodging
Cash or cash equivalent
|
โ | General | $343.26 |
| Incyte Corporation |
Travel and Lodging
Cash or cash equivalent
|
โ | General | $336.96 |
| Incyte Corporation |
Travel and Lodging
Cash or cash equivalent
|
โ | General | $197.00 |
| Incyte Corporation |
Travel and Lodging
Cash or cash equivalent
|
โ | General | $124.50 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $67.03 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
โ | General | $56.01 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
โ | General | $52.70 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
โ | General | $19.17 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
โ | General | $14.37 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2018โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2019โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
17003
Destruction of precancer skin growth, 2-14 growths
|
251 | 62 | $48.52 | $7.38 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
249 | 167 | $492.39 | $122.65 |
|
17000
Destruction of precancer skin growth, 1 growth
|
99 | 82 | $307.63 | $59.71 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
90 | 85 | $370.71 | $92.54 |
|
11102
Biopsy of related skin growth, first growth
|
68 | 63 | $400.82 | $94.97 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
67 | 39 | $662.93 | $167.14 |
|
11103
Biopsy of related skin growth, each additional growth
|
42 | 34 | $192.69 | $46.81 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
35 | 35 | $230.54 | $57.87 |
|
11900
Injection into skin growth, 1-7 growths
|
26 | 16 | $172.58 | $39.04 |
|
17110
Destruction of skin growth, 1-14 growths
|
21 | 18 | $427.67 | $104.72 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
21 | 21 | $713.90 | $162.14 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
16 | 16 | $70.63 | $17.01 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Cosentyx Sensoready (2 Pens) | Secukinumab | 98 | 2,751 | $1,035,152.96 | 11 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 67 | 2,010 | $1,633.64 | 26 |
| Ketoconazole | Ketoconazole | 63 | 2,657 | $905.25 | 34 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 52 | 1,642 | $613.48 | 39 |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 48 | 1,355 | $2,817.92 | 32 |
| Otezla | Apremilast | 47 | 1,406 | $220,566.94 | โ |
| Prednisone | Prednisone | 42 | 1,041 | $281.17 | 23 |
| Clobetasol Propionate | Clobetasol Propionate | 41 | 1,472 | $3,480.99 | 21 |
| Rinvoq | Upadacitinib | 41 | 1,390 | $351,652.73 | โ |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 40 | 624 | $745.12 | 20 |
| Spironolactone | Spironolactone | 35 | 2,865 | $782.25 | 13 |
| Metronidazole | Metronidazole | 33 | 1,166 | $1,503.30 | 21 |
| Clindamycin Phosphate | Clindamycin Phosphate | 33 | 930 | $1,001.87 | 14 |
| Dupixent Syringe | Dupilumab | 32 | 896 | $144,779.66 | โ |
| Mupirocin | Mupirocin | 30 | 602 | $265.45 | 21 |
| Dupixent Pen | Dupilumab | 30 | 812 | $108,235.57 | โ |
| Humira(Cf) Pen | Adalimumab | 28 | 952 | $601,343.74 | โ |
| Fluorouracil | Fluorouracil | 26 | 790 | $1,783.36 | 25 |
| Methotrexate | Methotrexate Sodium | 25 | 1,186 | $379.96 | โ |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | 1,034 | $1,631.69 | โ |
| Ammonium Lactate | Ammonium Lactate | 16 | 650 | $237.63 | โ |
| Minoxidil | Minoxidil | 16 | 1,438 | $75.90 | โ |
| Oxycodone Hcl | Oxycodone Hcl | 15 | 76 | $105.31 | 11 |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 15 | 442 | $158.03 | 12 |
| Tacrolimus | Tacrolimus | 15 | 540 | $2,000.30 | 13 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20190703002222
MA
7214245141
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Brigham And Womens Physicians Organization Inc
221 Longwood Ave, Boston, MA 021155804
Phone: 6177325500
Secondary Practice Locations
75 Francis St
Boston, MA 021156110
Phone: 6177325500
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Dermatology
MDPHD
Dermatology
Doctor of Medicine (M.D.)
Dermatology
Doctor of Medicine (M.D.)
Dermatology
Doctor of Medicine (M.D.)
Dermatology
Doctor of Medicine (M.D.)
Dermatology
Doctor of Medicine (M.D.), Master of Public Health
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 221 LONGWOOD AVE, BOSTON, MA 021155804 (Tel: 6177324918)
NPI status registered as active in NPPES database
Registered at 75 FRANCIS ST, BOSTON, MA 021156110 (Tel: 6177325500)
Registered at 75 FRANCIS ST, BOSTON, MA 021156110 (Tel: 6177325500)
Recorded as ALEXANDRA CHARROW, M.D.
Internal Medicine (license number reported to NPPES: MA 259131)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Boston
- Dr. Papri Sarkar, MD
- Dr. Alice Watson, MD, MPH
- Dr. Christopher Adams, MD
- Dr. Rebecca Dufner, MD, MBA
- Dr. Jessica Scanlon, MD
- Michelle Xiong
Mailing Address
75 Francis St
Boston, MA 021156110
Phone: 6177325500